Edition:
India

RaQualia Pharma Inc (4579.T)

4579.T on Tokyo Stock Exchange

1,375JPY
10:30am IST
Change (% chg)

¥-42 (-2.96%)
Prev Close
¥1,417
Open
¥1,424
Day's High
¥1,436
Day's Low
¥1,348
Volume
982,400
Avg. Vol
2,764,518
52-wk High
¥3,320
52-wk Low
¥885

Latest Key Developments (Source: Significant Developments)

RaQualia Pharma to sign license agreements with CJ HealthCare
Thursday, 28 Dec 2017 

Dec 28 (Reuters) - RaQualia Pharma Inc <4579.T>:Says it plans to sign license agreements with CJ HealthCare regarding RQ-00000004(tegoprazan) and crystal of RQ-00000004(tegoprazan) .  Full Article

RaQualia Pharma says termination of 5-HT4 partial agonist related license agreement
Thursday, 28 Dec 2017 

Dec 28 (Reuters) - RaQualia Pharma Inc <4579.T>:Says co and South Korea-based firm CJ HealthCare terminate 5-HT4 partial agonist (RQ-00000010) related license agreement .  Full Article

RaQualia Pharma signs license agreement with Maruho on selective Na sodium channel blocker
Monday, 25 Dec 2017 

Dec 25 (Reuters) - RaQualia Pharma Inc <4579.T> ::Says it and Maruho Co Ltd planed to enter into license agreement, regarding selective Na sodium channel blocker, on Dec. 25.  Full Article

RaQualia Pharma ends license agreement related to EP4 antagonist
Wednesday, 29 Nov 2017 

Nov 29 (Reuters) - RaQualia Pharma Inc <4579.T>:Says it ends license agreement with Maruishi Pharmaceutical Co Ltd regarding EP4 antagonist.  Full Article

RaQualia Pharma announces exercise of options
Monday, 16 Oct 2017 

Oct 16(Reuters) - RaQualia Pharma Inc <4579.T>:Says 1,000 units of its 14th series options were exercised to 1 million shares of its common stock, by Daiwa Securities Co. Ltd., during period from Oct. 10 to Oct. 16.  Full Article

RaQualia Pharma says exercise of options
Wednesday, 11 Oct 2017 

Oct 11 (Reuters) - RaQualia Pharma Inc <4579.T>:Says 100 units of its 14th series options were exercised to 100,000 shares of its stock on Oct. 11, at the price of 998.3 yen per share.  Full Article

RaQualia Pharma confirms to receive upfront payment
Thursday, 27 Jul 2017 

July 27 (Reuters) - RaQualia Pharma Inc <4579.T>:* Says it confirms to receive upfront payment from ASAHI KASEI PHARMA CORPORATION .  Full Article

RaQualia Pharma to fully acquire TMRC via stock swap
Monday, 26 Dec 2016 

RaQualia Pharma Inc <4579.T> : Says RaQualia Pharma enters into agreement to fully acquire TMRC Co Ltd which is engaged in anticarcinogen related business, through stock swap, with effective date on Feb. 3, 2017 . One share of TMRC's stock will be exchanged with 90 shares of co's stock .479,250 shares of co's stock will be exchanged.  Full Article

RaQualia Pharma gets substance patent for ghrelin receptor agonist(serine derivative) in Japan
Thursday, 6 Oct 2016 

RaQualia Pharma Inc <4579.T>: Says it received substance patent for ghrelin receptor agonist(serine derivative) in Japan .Says the substance is used for improvement of anorexia and suppression of body weight reduction.  Full Article

RaQualia Pharma gets sodium channel blocker patent allowance in China
Friday, 23 Sep 2016 

RaQualia Pharma Inc <4579.T>:Says it received an allowance for sodium channel blocker substance patent in China (Application No.201380022248.1).  Full Article

BRIEF-RaQualia Pharma plans pharmaceutical JV with ZTE Coming Biotech

* Says it plans to set up a JV, which will be engaged in research and development of pharmaceutical, with Shanghai-based firm ZTE Coming Biotech Co., Ltd, in May